Social Media
Home » Social Media
Pharma Marketers: Eight Things We Might Learn From Zappos.com
Thursday, July 22nd, 2010
Here’s my take after reading Delivering Happiness: A Path To Profits, Passion, and Purpose by Tony Hsieh CEO, Zappos.com, Inc. While it’s true that Zappos lives in a less regulated business environment than the pharmaceutical and healthcare industry, Tony’s standards for communicating with consumers are now part of the context of our work. Patients have come to expect Zappos- level experiences. This blog accepts that challenge: what might a pharma company or hospital might look like if Tony were CEO…
Read the full story
What Keeps Pharma Execs Awake At Night?
Wednesday, July 14th, 2010
Would it surprise you if 35 percent lie awake fretting over their commercial business models? Or if 24 percent lose sleep over their feeble pipelines? That number actually seems small, don’t you think
Read the full story
Silencing Critics Of A Pricey Gout Drug
Wednesday, July 7th, 2010
Here’s a lesson in social media. A number of rheumatologists are battling with URL Pharma over its new Colcrys med for treating gout, which is essentially a version of a very old drug called colchicine. Specifically, they complained about pricing on an online message board, and the drugmaker’s general counsel responded by sending letters to some docs about the “potential risks and liabiilty” of using unapproved versions, The Wall Street Journal writes.
Read the full story
Overvaluing social media
Tuesday, July 6th, 2010
In simple terms, a bubble just means that we overvalue something. Sometimes that thing we overvalue has no real value at all, and sometimes it’s wonderfully valuable and a victim of too much hype. It’s the latter that probably best describes the way we presently view social media relationships, especially where pharma is concerned.
Read the full story
Excuse me, the tactic has to be valuable to patients to be effective
Friday, July 2nd, 2010
Social media is not going to save the pharma industry and developing and launching iPhone apps that look good but have very little utility with patients is nothing but show and tell and a chance for DTC marketers to pat themselves on the back and say “look what I did!”. The fact of the matter is that in order to launch an application that your audience will actually use and want you have ask them some basic questions first like “what features do you want”. Pharma just goes to a vendor to develop these apps and takes one of their tools from their website and makes it an app and then everyone on Twitter says “look what they did”
Read the full story
Establishing trust with a skeptical public
Thursday, July 1st, 2010
Having a Twitter of Facebook account for your brand is not going to establish trust with a public that doesn’t trust you. It is, however, part of a multi-brand touch point effort to start down the path towards earning back trust. All the elements in your brand touch point have to earn trust, working together, much the same way that cylinders in an engine all work to move a vehicle forward
Read the full story
What’s Top of List in Your Social Media Implementation Plan?
Thursday, July 1st, 2010
Sanofi-Aventis recently experienced a FaceBook fiasco and learned from the experience (listen to this podcast: ” What Has Sanofi-Aventis Learned from Its Facebook Experience? “).
Posted in: Social Media | 0 Comments »
Read the full story
The danger of the Internet to inform and unite angry patients
Tuesday, June 29th, 2010
Sometimes when patients have a serious health condition for which there is no known cure they want, and, are willing to try anything to regain control of their lives. The Internet has allowed rumors, conjecture and misinformation to spread faster and penetrate the patient population deeper then ever before and according to an article in today/s Times it can lead to confusion and false hope. The article centers on MS patients who read about a vascular surgeons belief that MS maybe caused by narrowed veins in the neck and chest that block the drainage of blood from the brain.
Read the full story
Is pharma willing to take risks in social media marketing and learn from their mistakes ?
Monday, June 28th, 2010
Youʼre speeding to implementing social media in your company when you hear sounds that make the brakes squeal: “The procedures donʼt allow this.” “What will the FDA say ?.” “All conversations need to go through legal and regulatory.” Or worse, you request cooperation but donʼt get a response. You curse pharma bureaucrats for causing the screeching halt. You wonder if you should offer favors or pull strings to get things moving again because you know that you need a social media program but that “processes” just aren’t made to allow for speed.
Read the full story
Truth in Social Media & Pharma
Friday, June 25th, 2010
Jonathan Richman wrote a killer posting on the 10 things he’s tired of hearing in pharma social media and Sweet God was this needed!! Jon, you can’t see us, but I promise I am not the only one genuflecting in your general direction – THANK YOU!! So, take the kick in the ass folks, and then take a hard look at your brand goals – and go from there.
Read the full story
Business Week – Drug Marketing
Business Week – Pharma Marketing
Cafe Pharma
Clinical Trials.gov
FDA on Twitter
Pharma Live
Pharma Voice